Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress Juanjuan ZhaoMeirong WuYuhua Li Review Article 09 May 2020 Pages: 1681 - 1699
COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure Monia Marchetti Review Article 24 June 2020 Pages: 1701 - 1707
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma Maximilian MerzTobias DechowStefan Knop Review Article Open access 16 April 2020 Pages: 1709 - 1725
Long-term follow-up of a novel immunosuppressive strategy of cyclosporine alternatively combined with levamisole for severe aplastic anemia Jiali HuoXingxin LiYizhou Zheng Original Article 29 June 2020 Pages: 1727 - 1734
Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients Le-le ZhangXin-xin CaoJian Li Original Article 13 June 2020 Pages: 1735 - 1740
Necrotizing fasciitis in haematological patients: a different scenario A. Albasanz-PuigD Rodríguez-PardoI. Ruiz-Camps Original Article 12 May 2020 Pages: 1741 - 1747
Gene mutation profile in patients with acquired pure red cell aplasia Zhangbiao LongHongmin LiBing Han Original Article 27 June 2020 Pages: 1749 - 1754
Safety of bedside lumbar puncture in adult patients with thrombocytopenia Andrew Jay PortugueseAlessandra RothbergChris Jacob Original Article 20 June 2020 Pages: 1755 - 1762
Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenström macroglobulinemia Yan-Yan WuMing-Nan JiaXin-Xin Cao Original Article 23 June 2020 Pages: 1763 - 1769
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA Benoît TessoulinKamal BouabdallahSteven Le Gouill Original Article 29 June 2020 Pages: 1771 - 1778
Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients Juan DuJing LuJian Hou Original Article 27 June 2020 Pages: 1779 - 1791
Adverse event management in the TOURMALINE-MM3 study of post-transplant ixazomib maintenance in multiple myeloma Martin KaiserMeral BeksaçMeletios A. Dimopoulos Original Article Open access 01 July 2020 Pages: 1793 - 1804
Statin use and the risk of multiple myeloma: a PRISMA-compliant meta-analysis Pengcheng ZhangBing Liu Original Article 29 June 2020 Pages: 1805 - 1812
Risk and impact of invasive fungal infections in patients with multiple myeloma Chun-Kuang TsaiYao-Chung LiuJyh-Pyng Gau Original Article 01 July 2020 Pages: 1813 - 1822
Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma Hanne KuitunenElina KaprioOuti Kuittinen Original Article Open access 23 June 2020 Pages: 1823 - 1831
Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation Zongru LiYueyun LaiQian Jiang Original Article 23 June 2020 Pages: 1833 - 1843
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation Grzegorz HelbigAnna KoclęgaAgnieszka Karolczyk Original Article Open access 24 April 2020 Pages: 1845 - 1853
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC Amandine Le BourgeoisMyriam LabopinSociété Francophone de Greffe de Moelle et de Thérapie Cellulaire Original Article 20 June 2020 Pages: 1855 - 1862
Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen Lin LiYun LiYicheng Zhang Original Article 17 June 2020 Pages: 1863 - 1871
Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation Shuhei KurosawaNoriko DokiKazuteru Ohashi Original Article 25 May 2020 Pages: 1873 - 1882
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies Xiao-Ning GaoJi LinDai-Hong Liu Original Article 22 June 2020 Pages: 1883 - 1893
Measuring the cellular memory B cell response after vaccination in patients after allogeneic stem cell transplantation Julia WinklerHannes TittlbachThomas H. Winkler Original Article Open access 09 June 2020 Pages: 1895 - 1906
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma Christine EisfeldEva EßelingMatthias Stelljes Original Article Open access 22 May 2020 Pages: 1907 - 1915
De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia Lindsey RearighErica StohsAndrea Zimmer Original Article Open access 17 June 2020 Pages: 1917 - 1924
An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality Ritvan Kara AliSerkan SurmeNese Saltoglu Original Article 20 June 2020 Pages: 1925 - 1932
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments Yingying WangJingfeng LiFuling Zhou Original Article 29 June 2020 Pages: 1933 - 1938
COVID-19 presenting as neutropenic fever Hunter C. SpencerRiana Wurzburger Letter to the Editor 13 June 2020 Pages: 1939 - 1940
SARS-CoV-2 infection in children with febrile neutropenia Victoria FloresRaquel MirandaLénica A. Chávez-Aguilar Letter to the Editor 12 June 2020 Pages: 1941 - 1942
SARS-CoV-2-associated cold agglutinin disease: a report of two cases Tessa HuscenotJoris Gallandon behalf of the APHP Lariboisière COVID Group Letter to the Editor 26 June 2020 Pages: 1943 - 1944
Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease Luca RoncatiBeatrice LusentiAntonio Manenti Letter to the Editor 24 May 2020 Pages: 1945 - 1946
COVID-19, impact on myeloma patients Inès DufourJuliette RaedemaekerMarie-Christiane Vekemans Letter to the Editor 23 June 2020 Pages: 1947 - 1949
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection Michele MerliWalter AgenoPaolo Grossi Letter to the Editor 11 June 2020 Pages: 1951 - 1952